HIVE Digital Technologies Ltd. (NASDAQ: HIVE) Stock Competitors & Peer Comparison
See HIVE's competitors and their performance on the NASDAQ and across the wider stock market.
Peer Comparison Table: Information Technology Services Industry
Detailed financial metrics including price, market cap, P/E ratio, and more for HIVE and its NASDAQ peers.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| HIVE | $3.05 | +12.13% | 834.6M | -2.50 | -$1.22 | N/A |
| IBM | $234.71 | +1.30% | 221.1B | 19.76 | $11.88 | +2.89% |
| ACN | $193.12 | +2.90% | 118.2B | 14.10 | $13.70 | +3.36% |
| INFY | $12.09 | +1.00% | 49.1B | 14.59 | $0.83 | +4.33% |
| FI | $63.80 | +0.16% | 34.3B | 9.86 | $6.47 | N/A |
| CTSH | $64.64 | +1.96% | 29.1B | 11.73 | $5.51 | +2.01% |
| FISV | $52.73 | +1.44% | 28.1B | 8.15 | $6.47 | N/A |
| FIS | $42.28 | +0.98% | 21.9B | 7.01 | $6.03 | +4.00% |
| BR | $178.91 | +0.48% | 20.7B | 18.57 | $9.64 | +2.25% |
| CDW | $153.92 | +3.53% | 19.7B | 14.70 | $10.47 | +1.65% |
Stock Comparison
International Business Machines Corporation (NYSE: IBM)
HIVE vs IBM Comparison September 2026
HIVE Digital Technologies Ltd. (NASDAQ: HIVE) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HIVE stands at 834.6M. In comparison, IBM has a market cap of 221.1B. Regarding current trading prices, HIVE is priced at $3.05 on the NASDAQ, while IBM trades at $234.71.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HIVE currently has a P/E ratio of -2.50, whereas IBM's P/E ratio is 19.76. In terms of profitability, HIVE's ROE is -0.60%, compared to IBM's ROE of +0.34%. Regarding short-term risk, HIVE is more volatile compared to IBM. This indicates higher risk in terms of short-term price fluctuations for HIVE.Check IBM's competition here
Accenture plc (NYSE: ACN)
HIVE vs ACN Comparison September 2026
HIVE Digital Technologies Ltd. (NASDAQ: HIVE) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HIVE stands at 834.6M. In comparison, ACN has a market cap of 118.2B. Regarding current trading prices, HIVE is priced at $3.05 on the NASDAQ, while ACN trades at $193.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HIVE currently has a P/E ratio of -2.50, whereas ACN's P/E ratio is 14.10. In terms of profitability, HIVE's ROE is -0.60%, compared to ACN's ROE of +0.25%. Regarding short-term risk, HIVE is more volatile compared to ACN. This indicates higher risk in terms of short-term price fluctuations for HIVE.Check ACN's competition here
Infosys Limited (NYSE: INFY)
HIVE vs INFY Comparison September 2026
HIVE Digital Technologies Ltd. (NASDAQ: HIVE) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HIVE stands at 834.6M. In comparison, INFY has a market cap of 49.1B. Regarding current trading prices, HIVE is priced at $3.05 on the NASDAQ, while INFY trades at $12.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HIVE currently has a P/E ratio of -2.50, whereas INFY's P/E ratio is 14.59. In terms of profitability, HIVE's ROE is -0.60%, compared to INFY's ROE of +0.33%. Regarding short-term risk, HIVE is more volatile compared to INFY. This indicates higher risk in terms of short-term price fluctuations for HIVE.Check INFY's competition here
Fiserv, Inc. (NYSE: FI)
HIVE vs FI Comparison September 2026
HIVE Digital Technologies Ltd. (NASDAQ: HIVE) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HIVE stands at 834.6M. In comparison, FI has a market cap of 34.3B. Regarding current trading prices, HIVE is priced at $3.05 on the NASDAQ, while FI trades at $63.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HIVE currently has a P/E ratio of -2.50, whereas FI's P/E ratio is 9.86. In terms of profitability, HIVE's ROE is -0.60%, compared to FI's ROE of +0.11%. Regarding short-term risk, HIVE is more volatile compared to FI. This indicates higher risk in terms of short-term price fluctuations for HIVE.Check FI's competition here
Cognizant Technology Solutions Corporation (NASDAQ: CTSH)
HIVE vs CTSH Comparison September 2026
HIVE Digital Technologies Ltd. (NASDAQ: HIVE) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HIVE stands at 834.6M. In comparison, CTSH has a market cap of 29.1B. Regarding current trading prices, HIVE is priced at $3.05 on the NASDAQ, while CTSH trades at $64.64.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HIVE currently has a P/E ratio of -2.50, whereas CTSH's P/E ratio is 11.73. In terms of profitability, HIVE's ROE is -0.60%, compared to CTSH's ROE of +0.15%. Regarding short-term risk, HIVE is more volatile compared to CTSH. This indicates higher risk in terms of short-term price fluctuations for HIVE.Check CTSH's competition here
Fiserv, Inc. (NASDAQ: FISV)
HIVE vs FISV Comparison September 2026
HIVE Digital Technologies Ltd. (NASDAQ: HIVE) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HIVE stands at 834.6M. In comparison, FISV has a market cap of 28.1B. Regarding current trading prices, HIVE is priced at $3.05 on the NASDAQ, while FISV trades at $52.73.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HIVE currently has a P/E ratio of -2.50, whereas FISV's P/E ratio is 8.15. In terms of profitability, HIVE's ROE is -0.60%, compared to FISV's ROE of +0.11%. Regarding short-term risk, HIVE is more volatile compared to FISV. This indicates higher risk in terms of short-term price fluctuations for HIVE.Check FISV's competition here
Fidelity National Information Services, Inc. (NYSE: FIS)
HIVE vs FIS Comparison September 2026
HIVE Digital Technologies Ltd. (NASDAQ: HIVE) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HIVE stands at 834.6M. In comparison, FIS has a market cap of 21.9B. Regarding current trading prices, HIVE is priced at $3.05 on the NASDAQ, while FIS trades at $42.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HIVE currently has a P/E ratio of -2.50, whereas FIS's P/E ratio is 7.01. In terms of profitability, HIVE's ROE is -0.60%, compared to FIS's ROE of +0.23%. Regarding short-term risk, HIVE is more volatile compared to FIS. This indicates higher risk in terms of short-term price fluctuations for HIVE.Check FIS's competition here
Broadridge Financial Solutions, Inc. (NYSE: BR)
HIVE vs BR Comparison September 2026
HIVE Digital Technologies Ltd. (NASDAQ: HIVE) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HIVE stands at 834.6M. In comparison, BR has a market cap of 20.7B. Regarding current trading prices, HIVE is priced at $3.05 on the NASDAQ, while BR trades at $178.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HIVE currently has a P/E ratio of -2.50, whereas BR's P/E ratio is 18.57. In terms of profitability, HIVE's ROE is -0.60%, compared to BR's ROE of +0.40%. Regarding short-term risk, HIVE is more volatile compared to BR. This indicates higher risk in terms of short-term price fluctuations for HIVE.Check BR's competition here
CDW Corporation (NASDAQ: CDW)
HIVE vs CDW Comparison September 2026
HIVE Digital Technologies Ltd. (NASDAQ: HIVE) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HIVE stands at 834.6M. In comparison, CDW has a market cap of 19.7B. Regarding current trading prices, HIVE is priced at $3.05 on the NASDAQ, while CDW trades at $153.92.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HIVE currently has a P/E ratio of -2.50, whereas CDW's P/E ratio is 14.70. In terms of profitability, HIVE's ROE is -0.60%, compared to CDW's ROE of +0.43%. Regarding short-term risk, HIVE is more volatile compared to CDW. This indicates higher risk in terms of short-term price fluctuations for HIVE.Check CDW's competition here
Wipro Limited (NYSE: WIT)
HIVE vs WIT Comparison September 2026
HIVE Digital Technologies Ltd. (NASDAQ: HIVE) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HIVE stands at 834.6M. In comparison, WIT has a market cap of 17.8B. Regarding current trading prices, HIVE is priced at $3.05 on the NASDAQ, while WIT trades at $1.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HIVE currently has a P/E ratio of -2.50, whereas WIT's P/E ratio is 13.29. In terms of profitability, HIVE's ROE is -0.60%, compared to WIT's ROE of +0.15%. Regarding short-term risk, HIVE is more volatile compared to WIT. This indicates higher risk in terms of short-term price fluctuations for HIVE.Check WIT's competition here
Leidos Holdings, Inc. (NYSE: LDOS)
HIVE vs LDOS Comparison September 2026
HIVE Digital Technologies Ltd. (NASDAQ: HIVE) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HIVE stands at 834.6M. In comparison, LDOS has a market cap of 16.7B. Regarding current trading prices, HIVE is priced at $3.05 on the NASDAQ, while LDOS trades at $132.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HIVE currently has a P/E ratio of -2.50, whereas LDOS's P/E ratio is 10.85. In terms of profitability, HIVE's ROE is -0.60%, compared to LDOS's ROE of +0.28%. Regarding short-term risk, HIVE is more volatile compared to LDOS. This indicates higher risk in terms of short-term price fluctuations for HIVE.Check LDOS's competition here
CGI Inc. (NYSE: GIB)
HIVE vs GIB Comparison September 2026
HIVE Digital Technologies Ltd. (NASDAQ: HIVE) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HIVE stands at 834.6M. In comparison, GIB has a market cap of 16B. Regarding current trading prices, HIVE is priced at $3.05 on the NASDAQ, while GIB trades at $74.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HIVE currently has a P/E ratio of -2.50, whereas GIB's P/E ratio is 12.02. In terms of profitability, HIVE's ROE is -0.60%, compared to GIB's ROE of +0.17%. Regarding short-term risk, HIVE is more volatile compared to GIB. This indicates higher risk in terms of short-term price fluctuations for HIVE.Check GIB's competition here
IREN Limited (NASDAQ: IREN)
HIVE vs IREN Comparison September 2026
HIVE Digital Technologies Ltd. (NASDAQ: HIVE) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HIVE stands at 834.6M. In comparison, IREN has a market cap of 14.9B. Regarding current trading prices, HIVE is priced at $3.05 on the NASDAQ, while IREN trades at $41.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HIVE currently has a P/E ratio of -2.50, whereas IREN's P/E ratio is -28.92. In terms of profitability, HIVE's ROE is -0.60%, compared to IREN's ROE of -0.23%. Regarding short-term risk, HIVE is more volatile compared to IREN. This indicates higher risk in terms of short-term price fluctuations for HIVE.Check IREN's competition here
CACI International Inc (NYSE: CACI)
HIVE vs CACI Comparison September 2026
HIVE Digital Technologies Ltd. (NASDAQ: HIVE) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HIVE stands at 834.6M. In comparison, CACI has a market cap of 13.9B. Regarding current trading prices, HIVE is priced at $3.05 on the NASDAQ, while CACI trades at $630.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HIVE currently has a P/E ratio of -2.50, whereas CACI's P/E ratio is 21.13. In terms of profitability, HIVE's ROE is -0.60%, compared to CACI's ROE of +0.13%. Regarding short-term risk, HIVE is more volatile compared to CACI. This indicates higher risk in terms of short-term price fluctuations for HIVE.Check CACI's competition here
Wise Group plc Class A Ordinary Shares (NASDAQ: WSE)
HIVE vs WSE Comparison September 2026
HIVE Digital Technologies Ltd. (NASDAQ: HIVE) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HIVE stands at 834.6M. In comparison, WSE has a market cap of 13.2B. Regarding current trading prices, HIVE is priced at $3.05 on the NASDAQ, while WSE trades at $13.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HIVE currently has a P/E ratio of -2.50, whereas WSE's P/E ratio is 13.47. In terms of profitability, HIVE's ROE is -0.60%, compared to WSE's ROE of +0.26%. Regarding short-term risk, HIVE is more volatile compared to WSE. This indicates higher risk in terms of short-term price fluctuations for HIVE.Check WSE's competition here
Gartner, Inc. (NYSE: IT)
HIVE vs IT Comparison September 2026
HIVE Digital Technologies Ltd. (NASDAQ: HIVE) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HIVE stands at 834.6M. In comparison, IT has a market cap of 13.1B. Regarding current trading prices, HIVE is priced at $3.05 on the NASDAQ, while IT trades at $195.46.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HIVE currently has a P/E ratio of -2.50, whereas IT's P/E ratio is 13.59. In terms of profitability, HIVE's ROE is -0.60%, compared to IT's ROE of +4.01%. Regarding short-term risk, HIVE is more volatile compared to IT. This indicates higher risk in terms of short-term price fluctuations for HIVE.Check IT's competition here
Jack Henry & Associates, Inc. (NASDAQ: JKHY)
HIVE vs JKHY Comparison September 2026
HIVE Digital Technologies Ltd. (NASDAQ: HIVE) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HIVE stands at 834.6M. In comparison, JKHY has a market cap of 12B. Regarding current trading prices, HIVE is priced at $3.05 on the NASDAQ, while JKHY trades at $168.37.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HIVE currently has a P/E ratio of -2.50, whereas JKHY's P/E ratio is 23.55. In terms of profitability, HIVE's ROE is -0.60%, compared to JKHY's ROE of +0.23%. Regarding short-term risk, HIVE is more volatile compared to JKHY. This indicates higher risk in terms of short-term price fluctuations for HIVE.Check JKHY's competition here
Applied Digital Corp. (NASDAQ: APLD)
HIVE vs APLD Comparison September 2026
HIVE Digital Technologies Ltd. (NASDAQ: HIVE) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HIVE stands at 834.6M. In comparison, APLD has a market cap of 7.5B. Regarding current trading prices, HIVE is priced at $3.05 on the NASDAQ, while APLD trades at $25.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HIVE currently has a P/E ratio of -2.50, whereas APLD's P/E ratio is -37.01. In terms of profitability, HIVE's ROE is -0.60%, compared to APLD's ROE of -0.17%. Regarding short-term risk, HIVE is more volatile compared to APLD. This indicates higher risk in terms of short-term price fluctuations for HIVE.Check APLD's competition here
Cipher Mining Inc. (NASDAQ: CIFR)
HIVE vs CIFR Comparison September 2026
HIVE Digital Technologies Ltd. (NASDAQ: HIVE) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HIVE stands at 834.6M. In comparison, CIFR has a market cap of 7.1B. Regarding current trading prices, HIVE is priced at $3.05 on the NASDAQ, while CIFR trades at $17.37.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HIVE currently has a P/E ratio of -2.50, whereas CIFR's P/E ratio is -6.07. In terms of profitability, HIVE's ROE is -0.60%, compared to CIFR's ROE of -1.56%. Regarding short-term risk, HIVE is less volatile compared to CIFR. This indicates lower risk in terms of short-term price fluctuations for HIVE.Check CIFR's competition here
Ingram Micro Holding Corporation (NYSE: INGM)
HIVE vs INGM Comparison September 2026
HIVE Digital Technologies Ltd. (NASDAQ: HIVE) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HIVE stands at 834.6M. In comparison, INGM has a market cap of 6.6B. Regarding current trading prices, HIVE is priced at $3.05 on the NASDAQ, while INGM trades at $28.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HIVE currently has a P/E ratio of -2.50, whereas INGM's P/E ratio is 9.39. In terms of profitability, HIVE's ROE is -0.60%, compared to INGM's ROE of +0.10%. Regarding short-term risk, HIVE is more volatile compared to INGM. This indicates higher risk in terms of short-term price fluctuations for HIVE.Check INGM's competition here
Genpact Limited (NYSE: G)
HIVE vs G Comparison September 2026
HIVE Digital Technologies Ltd. (NASDAQ: HIVE) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HIVE stands at 834.6M. In comparison, G has a market cap of 6.4B. Regarding current trading prices, HIVE is priced at $3.05 on the NASDAQ, while G trades at $38.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HIVE currently has a P/E ratio of -2.50, whereas G's P/E ratio is 9.86. In terms of profitability, HIVE's ROE is -0.60%, compared to G's ROE of +0.23%. Regarding short-term risk, HIVE is more volatile compared to G. This indicates higher risk in terms of short-term price fluctuations for HIVE.Check G's competition here
EPAM Systems, Inc. (NYSE: EPAM)
HIVE vs EPAM Comparison September 2026
HIVE Digital Technologies Ltd. (NASDAQ: HIVE) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HIVE stands at 834.6M. In comparison, EPAM has a market cap of 6.3B. Regarding current trading prices, HIVE is priced at $3.05 on the NASDAQ, while EPAM trades at $119.88.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HIVE currently has a P/E ratio of -2.50, whereas EPAM's P/E ratio is 9.53. In terms of profitability, HIVE's ROE is -0.60%, compared to EPAM's ROE of +0.11%. Regarding short-term risk, HIVE is more volatile compared to EPAM. This indicates higher risk in terms of short-term price fluctuations for HIVE.Check EPAM's competition here
GDS Holdings Limited (NASDAQ: GDS)
HIVE vs GDS Comparison September 2026
HIVE Digital Technologies Ltd. (NASDAQ: HIVE) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HIVE stands at 834.6M. In comparison, GDS has a market cap of 6.1B. Regarding current trading prices, HIVE is priced at $3.05 on the NASDAQ, while GDS trades at $31.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HIVE currently has a P/E ratio of -2.50, whereas GDS's P/E ratio is 12.55. In terms of profitability, HIVE's ROE is -0.60%, compared to GDS's ROE of +0.13%. Regarding short-term risk, HIVE is more volatile compared to GDS. This indicates higher risk in terms of short-term price fluctuations for HIVE.Check GDS's competition here
ExlService Holdings, Inc. (NASDAQ: EXLS)
HIVE vs EXLS Comparison September 2026
HIVE Digital Technologies Ltd. (NASDAQ: HIVE) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HIVE stands at 834.6M. In comparison, EXLS has a market cap of 5.7B. Regarding current trading prices, HIVE is priced at $3.05 on the NASDAQ, while EXLS trades at $37.32.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HIVE currently has a P/E ratio of -2.50, whereas EXLS's P/E ratio is 18.20. In terms of profitability, HIVE's ROE is -0.60%, compared to EXLS's ROE of +0.28%. Regarding short-term risk, HIVE is more volatile compared to EXLS. This indicates higher risk in terms of short-term price fluctuations for HIVE.Check EXLS's competition here
Science Applications International Corporation (NASDAQ: SAIC)
HIVE vs SAIC Comparison September 2026
HIVE Digital Technologies Ltd. (NASDAQ: HIVE) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HIVE stands at 834.6M. In comparison, SAIC has a market cap of 5.3B. Regarding current trading prices, HIVE is priced at $3.05 on the NASDAQ, while SAIC trades at $126.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HIVE currently has a P/E ratio of -2.50, whereas SAIC's P/E ratio is 11.36. In terms of profitability, HIVE's ROE is -0.60%, compared to SAIC's ROE of +0.26%. Regarding short-term risk, HIVE is more volatile compared to SAIC. This indicates higher risk in terms of short-term price fluctuations for HIVE.Check SAIC's competition here
Parsons Corporation (NYSE: PSN)
HIVE vs PSN Comparison September 2026
HIVE Digital Technologies Ltd. (NASDAQ: HIVE) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HIVE stands at 834.6M. In comparison, PSN has a market cap of 5B. Regarding current trading prices, HIVE is priced at $3.05 on the NASDAQ, while PSN trades at $46.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HIVE currently has a P/E ratio of -2.50, whereas PSN's P/E ratio is 19.81. In terms of profitability, HIVE's ROE is -0.60%, compared to PSN's ROE of +0.06%. Regarding short-term risk, HIVE is more volatile compared to PSN. This indicates higher risk in terms of short-term price fluctuations for HIVE.Check PSN's competition here
Insight Enterprises, Inc. (NASDAQ: NSIT)
HIVE vs NSIT Comparison September 2026
HIVE Digital Technologies Ltd. (NASDAQ: HIVE) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HIVE stands at 834.6M. In comparison, NSIT has a market cap of 4.8B. Regarding current trading prices, HIVE is priced at $3.05 on the NASDAQ, while NSIT trades at $159.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HIVE currently has a P/E ratio of -2.50, whereas NSIT's P/E ratio is 13.12. In terms of profitability, HIVE's ROE is -0.60%, compared to NSIT's ROE of +0.13%. Regarding short-term risk, HIVE is more volatile compared to NSIT. This indicates higher risk in terms of short-term price fluctuations for HIVE.Check NSIT's competition here
NCR Corporation (NYSE: NCR)
HIVE vs NCR Comparison September 2026
HIVE Digital Technologies Ltd. (NASDAQ: HIVE) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HIVE stands at 834.6M. In comparison, NCR has a market cap of 3.8B. Regarding current trading prices, HIVE is priced at $3.05 on the NASDAQ, while NCR trades at $27.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HIVE currently has a P/E ratio of -2.50, whereas NCR's P/E ratio is 49.24. In terms of profitability, HIVE's ROE is -0.60%, compared to NCR's ROE of +0.17%. Regarding short-term risk, HIVE is more volatile compared to NCR. This indicates higher risk in terms of short-term price fluctuations for HIVE.Check NCR's competition here
WNS (Holdings) Limited (NYSE: WNS)
HIVE vs WNS Comparison September 2026
HIVE Digital Technologies Ltd. (NASDAQ: HIVE) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HIVE stands at 834.6M. In comparison, WNS has a market cap of 3.3B. Regarding current trading prices, HIVE is priced at $3.05 on the NASDAQ, while WNS trades at $76.48.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HIVE currently has a P/E ratio of -2.50, whereas WNS's P/E ratio is 21.36. In terms of profitability, HIVE's ROE is -0.60%, compared to WNS's ROE of +0.09%. Regarding short-term risk, HIVE is more volatile compared to WNS. This indicates higher risk in terms of short-term price fluctuations for HIVE.Check WNS's competition here
Kyndryl Holdings, Inc. (NYSE: KD)
HIVE vs KD Comparison September 2026
HIVE Digital Technologies Ltd. (NASDAQ: HIVE) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HIVE stands at 834.6M. In comparison, KD has a market cap of 2.9B. Regarding current trading prices, HIVE is priced at $3.05 on the NASDAQ, while KD trades at $13.34.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HIVE currently has a P/E ratio of -2.50, whereas KD's P/E ratio is 13.90. In terms of profitability, HIVE's ROE is -0.60%, compared to KD's ROE of +0.29%. Regarding short-term risk, HIVE is more volatile compared to KD. This indicates higher risk in terms of short-term price fluctuations for HIVE.Check KD's competition here
Csquare Inc. (NYSE: CSQR)
HIVE vs CSQR Comparison September 2026
HIVE Digital Technologies Ltd. (NASDAQ: HIVE) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HIVE stands at 834.6M. In comparison, CSQR has a market cap of 2.8B. Regarding current trading prices, HIVE is priced at $3.05 on the NASDAQ, while CSQR trades at $18.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HIVE currently has a P/E ratio of -2.50, whereas CSQR's P/E ratio is N/A. In terms of profitability, HIVE's ROE is -0.60%, compared to CSQR's ROE of N/A. Regarding short-term risk, HIVE is more volatile compared to CSQR. This indicates higher risk in terms of short-term price fluctuations for HIVE.Check CSQR's competition here
Perficient, Inc. (NASDAQ: PRFT)
HIVE vs PRFT Comparison September 2026
HIVE Digital Technologies Ltd. (NASDAQ: HIVE) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HIVE stands at 834.6M. In comparison, PRFT has a market cap of 2.7B. Regarding current trading prices, HIVE is priced at $3.05 on the NASDAQ, while PRFT trades at $75.96.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HIVE currently has a P/E ratio of -2.50, whereas PRFT's P/E ratio is 36.34. In terms of profitability, HIVE's ROE is -0.60%, compared to PRFT's ROE of +0.21%. Regarding short-term risk, HIVE is more volatile compared to PRFT. This indicates higher risk in terms of short-term price fluctuations for HIVE.Check PRFT's competition here
Keel Infrastructure Corp. (NASDAQ: KEEL)
HIVE vs KEEL Comparison September 2026
HIVE Digital Technologies Ltd. (NASDAQ: HIVE) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HIVE stands at 834.6M. In comparison, KEEL has a market cap of 2B. Regarding current trading prices, HIVE is priced at $3.05 on the NASDAQ, while KEEL trades at $3.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HIVE currently has a P/E ratio of -2.50, whereas KEEL's P/E ratio is N/A. In terms of profitability, HIVE's ROE is -0.60%, compared to KEEL's ROE of -0.90%. Regarding short-term risk, HIVE is more volatile compared to KEEL. This indicates higher risk in terms of short-term price fluctuations for HIVE.Check KEEL's competition here
Concentrix Corporation (NASDAQ: CNXC)
HIVE vs CNXC Comparison September 2026
HIVE Digital Technologies Ltd. (NASDAQ: HIVE) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HIVE stands at 834.6M. In comparison, CNXC has a market cap of 2B. Regarding current trading prices, HIVE is priced at $3.05 on the NASDAQ, while CNXC trades at $32.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HIVE currently has a P/E ratio of -2.50, whereas CNXC's P/E ratio is 2.99. In terms of profitability, HIVE's ROE is -0.60%, compared to CNXC's ROE of -0.42%. Regarding short-term risk, HIVE is more volatile compared to CNXC. This indicates higher risk in terms of short-term price fluctuations for HIVE.Check CNXC's competition here
Formula Systems (1985) Ltd. (NASDAQ: FORTY)
HIVE vs FORTY Comparison September 2026
HIVE Digital Technologies Ltd. (NASDAQ: HIVE) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HIVE stands at 834.6M. In comparison, FORTY has a market cap of 2B. Regarding current trading prices, HIVE is priced at $3.05 on the NASDAQ, while FORTY trades at $129.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HIVE currently has a P/E ratio of -2.50, whereas FORTY's P/E ratio is 30.30. In terms of profitability, HIVE's ROE is -0.60%, compared to FORTY's ROE of +0.54%. Regarding short-term risk, HIVE is more volatile compared to FORTY. This indicates higher risk in terms of short-term price fluctuations for HIVE.Check FORTY's competition here
SharonAI Holdings, Inc. Class A Common Stock (NASDAQ: SHAZ)
HIVE vs SHAZ Comparison September 2026
HIVE Digital Technologies Ltd. (NASDAQ: HIVE) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HIVE stands at 834.6M. In comparison, SHAZ has a market cap of 1.9B. Regarding current trading prices, HIVE is priced at $3.05 on the NASDAQ, while SHAZ trades at $54.97.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HIVE currently has a P/E ratio of -2.50, whereas SHAZ's P/E ratio is -1.80. In terms of profitability, HIVE's ROE is -0.60%, compared to SHAZ's ROE of -1.57%. Regarding short-term risk, HIVE is more volatile compared to SHAZ. This indicates higher risk in terms of short-term price fluctuations for HIVE.Check SHAZ's competition here
DXC Technology Company (NYSE: DXC)
HIVE vs DXC Comparison September 2026
HIVE Digital Technologies Ltd. (NASDAQ: HIVE) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HIVE stands at 834.6M. In comparison, DXC has a market cap of 1.9B. Regarding current trading prices, HIVE is priced at $3.05 on the NASDAQ, while DXC trades at $11.67.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HIVE currently has a P/E ratio of -2.50, whereas DXC's P/E ratio is 3.59. In terms of profitability, HIVE's ROE is -0.60%, compared to DXC's ROE of +0.04%. Regarding short-term risk, HIVE is more volatile compared to DXC. This indicates higher risk in terms of short-term price fluctuations for HIVE.Check DXC's competition here
Innodata Inc. (NASDAQ: INOD)
HIVE vs INOD Comparison September 2026
HIVE Digital Technologies Ltd. (NASDAQ: HIVE) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HIVE stands at 834.6M. In comparison, INOD has a market cap of 1.8B. Regarding current trading prices, HIVE is priced at $3.05 on the NASDAQ, while INOD trades at $55.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HIVE currently has a P/E ratio of -2.50, whereas INOD's P/E ratio is 49.59. In terms of profitability, HIVE's ROE is -0.60%, compared to INOD's ROE of +0.38%. Regarding short-term risk, HIVE is more volatile compared to INOD. This indicates higher risk in terms of short-term price fluctuations for HIVE.Check INOD's competition here
Globant S.A. (NYSE: GLOB)
HIVE vs GLOB Comparison September 2026
HIVE Digital Technologies Ltd. (NASDAQ: HIVE) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HIVE stands at 834.6M. In comparison, GLOB has a market cap of 1.7B. Regarding current trading prices, HIVE is priced at $3.05 on the NASDAQ, while GLOB trades at $40.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HIVE currently has a P/E ratio of -2.50, whereas GLOB's P/E ratio is 6.61. In terms of profitability, HIVE's ROE is -0.60%, compared to GLOB's ROE of +0.05%. Regarding short-term risk, HIVE is more volatile compared to GLOB. This indicates higher risk in terms of short-term price fluctuations for HIVE.Check GLOB's competition here
VNET Group, Inc. (NASDAQ: VNET)
HIVE vs VNET Comparison September 2026
HIVE Digital Technologies Ltd. (NASDAQ: HIVE) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HIVE stands at 834.6M. In comparison, VNET has a market cap of 1.7B. Regarding current trading prices, HIVE is priced at $3.05 on the NASDAQ, while VNET trades at $6.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HIVE currently has a P/E ratio of -2.50, whereas VNET's P/E ratio is -5.16. In terms of profitability, HIVE's ROE is -0.60%, compared to VNET's ROE of -0.47%. Regarding short-term risk, HIVE is more volatile compared to VNET. This indicates higher risk in terms of short-term price fluctuations for HIVE.Check VNET's competition here
Mega Fortune Company Limited (NASDAQ: MGRT)
HIVE vs MGRT Comparison September 2026
HIVE Digital Technologies Ltd. (NASDAQ: HIVE) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HIVE stands at 834.6M. In comparison, MGRT has a market cap of 1.5B. Regarding current trading prices, HIVE is priced at $3.05 on the NASDAQ, while MGRT trades at $107.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HIVE currently has a P/E ratio of -2.50, whereas MGRT's P/E ratio is 634.71. In terms of profitability, HIVE's ROE is -0.60%, compared to MGRT's ROE of +0.21%. Regarding short-term risk, HIVE is more volatile compared to MGRT. This indicates higher risk in terms of short-term price fluctuations for HIVE.Check MGRT's competition here
Thoughtworks Holding, Inc. (NASDAQ: TWKS)
HIVE vs TWKS Comparison September 2026
HIVE Digital Technologies Ltd. (NASDAQ: HIVE) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HIVE stands at 834.6M. In comparison, TWKS has a market cap of 1.4B. Regarding current trading prices, HIVE is priced at $3.05 on the NASDAQ, while TWKS trades at $4.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HIVE currently has a P/E ratio of -2.50, whereas TWKS's P/E ratio is -12.08. In terms of profitability, HIVE's ROE is -0.60%, compared to TWKS's ROE of -0.09%. Regarding short-term risk, HIVE is more volatile compared to TWKS. This indicates higher risk in terms of short-term price fluctuations for HIVE.Check TWKS's competition here
BigBear.ai Holdings, Inc. (NYSE: BBAI)
HIVE vs BBAI Comparison September 2026
HIVE Digital Technologies Ltd. (NASDAQ: HIVE) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HIVE stands at 834.6M. In comparison, BBAI has a market cap of 1.4B. Regarding current trading prices, HIVE is priced at $3.05 on the NASDAQ, while BBAI trades at $2.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HIVE currently has a P/E ratio of -2.50, whereas BBAI's P/E ratio is -4.33. In terms of profitability, HIVE's ROE is -0.60%, compared to BBAI's ROE of -0.12%. Regarding short-term risk, HIVE is more volatile compared to BBAI. This indicates higher risk in terms of short-term price fluctuations for HIVE.Check BBAI's competition here
Clarivate Plc (NYSE: CLVT)
HIVE vs CLVT Comparison September 2026
HIVE Digital Technologies Ltd. (NASDAQ: HIVE) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HIVE stands at 834.6M. In comparison, CLVT has a market cap of 1.4B. Regarding current trading prices, HIVE is priced at $3.05 on the NASDAQ, while CLVT trades at $2.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HIVE currently has a P/E ratio of -2.50, whereas CLVT's P/E ratio is 2.90. In terms of profitability, HIVE's ROE is -0.60%, compared to CLVT's ROE of -0.07%. Regarding short-term risk, HIVE is more volatile compared to CLVT. This indicates higher risk in terms of short-term price fluctuations for HIVE.Check CLVT's competition here
Everforth, Inc. (NYSE: EFOR)
HIVE vs EFOR Comparison September 2026
HIVE Digital Technologies Ltd. (NASDAQ: HIVE) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HIVE stands at 834.6M. In comparison, EFOR has a market cap of 1.3B. Regarding current trading prices, HIVE is priced at $3.05 on the NASDAQ, while EFOR trades at $31.83.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HIVE currently has a P/E ratio of -2.50, whereas EFOR's P/E ratio is 7.37. In terms of profitability, HIVE's ROE is -0.60%, compared to EFOR's ROE of +0.05%. Regarding short-term risk, HIVE is more volatile compared to EFOR. This indicates higher risk in terms of short-term price fluctuations for HIVE.Check EFOR's competition here
Bitfarms Ltd. (NASDAQ: BITF)
HIVE vs BITF Comparison September 2026
HIVE Digital Technologies Ltd. (NASDAQ: HIVE) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HIVE stands at 834.6M. In comparison, BITF has a market cap of 1.3B. Regarding current trading prices, HIVE is priced at $3.05 on the NASDAQ, while BITF trades at $2.16.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HIVE currently has a P/E ratio of -2.50, whereas BITF's P/E ratio is -5.68. In terms of profitability, HIVE's ROE is -0.60%, compared to BITF's ROE of -0.90%. Regarding short-term risk, HIVE is more volatile compared to BITF. This indicates higher risk in terms of short-term price fluctuations for HIVE.Check BITF's competition here
BIT Mining Limited (NYSE: BTCM)
HIVE vs BTCM Comparison September 2026
HIVE Digital Technologies Ltd. (NASDAQ: HIVE) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HIVE stands at 834.6M. In comparison, BTCM has a market cap of 1.3B. Regarding current trading prices, HIVE is priced at $3.05 on the NASDAQ, while BTCM trades at $1.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HIVE currently has a P/E ratio of -2.50, whereas BTCM's P/E ratio is -0.53. In terms of profitability, HIVE's ROE is -0.60%, compared to BTCM's ROE of -0.32%. Regarding short-term risk, HIVE is more volatile compared to BTCM. This indicates higher risk in terms of short-term price fluctuations for HIVE.Check BTCM's competition here
NCR Voyix Corporation (NYSE: VYX)
HIVE vs VYX Comparison September 2026
HIVE Digital Technologies Ltd. (NASDAQ: HIVE) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HIVE stands at 834.6M. In comparison, VYX has a market cap of 1.2B. Regarding current trading prices, HIVE is priced at $3.05 on the NASDAQ, while VYX trades at $8.96.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HIVE currently has a P/E ratio of -2.50, whereas VYX's P/E ratio is 10.07. In terms of profitability, HIVE's ROE is -0.60%, compared to VYX's ROE of +0.07%. Regarding short-term risk, HIVE is more volatile compared to VYX. This indicates higher risk in terms of short-term price fluctuations for HIVE.Check VYX's competition here
ASGN Incorporated (NYSE: ASGN)
HIVE vs ASGN Comparison September 2026
HIVE Digital Technologies Ltd. (NASDAQ: HIVE) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HIVE stands at 834.6M. In comparison, ASGN has a market cap of 895M. Regarding current trading prices, HIVE is priced at $3.05 on the NASDAQ, while ASGN trades at $20.96.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HIVE currently has a P/E ratio of -2.50, whereas ASGN's P/E ratio is 9.32. In terms of profitability, HIVE's ROE is -0.60%, compared to ASGN's ROE of +0.05%. Regarding short-term risk, HIVE is more volatile compared to ASGN. This indicates higher risk in terms of short-term price fluctuations for HIVE.Check ASGN's competition here
SOLAI Limited (NYSE: SLAI)
HIVE vs SLAI Comparison September 2026
HIVE Digital Technologies Ltd. (NASDAQ: HIVE) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HIVE stands at 834.6M. In comparison, SLAI has a market cap of 880.1M. Regarding current trading prices, HIVE is priced at $3.05 on the NASDAQ, while SLAI trades at $3.72.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HIVE currently has a P/E ratio of -2.50, whereas SLAI's P/E ratio is -1.40. In terms of profitability, HIVE's ROE is -0.60%, compared to SLAI's ROE of -0.83%. Regarding short-term risk, HIVE is less volatile compared to SLAI. This indicates lower risk in terms of short-term price fluctuations for HIVE.Check SLAI's competition here
Magic Software Enterprises Ltd. (NASDAQ: MGIC)
HIVE vs MGIC Comparison September 2026
HIVE Digital Technologies Ltd. (NASDAQ: HIVE) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HIVE stands at 834.6M. In comparison, MGIC has a market cap of 853.3M. Regarding current trading prices, HIVE is priced at $3.05 on the NASDAQ, while MGIC trades at $17.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HIVE currently has a P/E ratio of -2.50, whereas MGIC's P/E ratio is 21.20. In terms of profitability, HIVE's ROE is -0.60%, compared to MGIC's ROE of +0.11%. Regarding short-term risk, HIVE is more volatile compared to MGIC. This indicates higher risk in terms of short-term price fluctuations for HIVE.Check MGIC's competition here
Cantaloupe, Inc. (NASDAQ: CTLP)
HIVE vs CTLP Comparison September 2026
HIVE Digital Technologies Ltd. (NASDAQ: HIVE) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HIVE stands at 834.6M. In comparison, CTLP has a market cap of 825.8M. Regarding current trading prices, HIVE is priced at $3.05 on the NASDAQ, while CTLP trades at $11.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HIVE currently has a P/E ratio of -2.50, whereas CTLP's P/E ratio is 280.00. In terms of profitability, HIVE's ROE is -0.60%, compared to CTLP's ROE of +0.01%. Regarding short-term risk, HIVE is more volatile compared to CTLP. This indicates higher risk in terms of short-term price fluctuations for HIVE.Check CTLP's competition here
Clarivate Plc (NYSE: CLVT-PA)
HIVE vs CLVT-PA Comparison September 2026
HIVE Digital Technologies Ltd. (NASDAQ: HIVE) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HIVE stands at 834.6M. In comparison, CLVT-PA has a market cap of 755.5M. Regarding current trading prices, HIVE is priced at $3.05 on the NASDAQ, while CLVT-PA trades at $4.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HIVE currently has a P/E ratio of -2.50, whereas CLVT-PA's P/E ratio is -7.93. In terms of profitability, HIVE's ROE is -0.60%, compared to CLVT-PA's ROE of -0.07%. Regarding short-term risk, HIVE is more volatile compared to CLVT-PA. This indicates higher risk in terms of short-term price fluctuations for HIVE.Check CLVT-PA's competition here
N-able, Inc. (NYSE: NABL)
HIVE vs NABL Comparison September 2026
HIVE Digital Technologies Ltd. (NASDAQ: HIVE) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HIVE stands at 834.6M. In comparison, NABL has a market cap of 750.7M. Regarding current trading prices, HIVE is priced at $3.05 on the NASDAQ, while NABL trades at $3.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HIVE currently has a P/E ratio of -2.50, whereas NABL's P/E ratio is 10.22. In terms of profitability, HIVE's ROE is -0.60%, compared to NABL's ROE of -0.01%. Regarding short-term risk, HIVE is more volatile compared to NABL. This indicates higher risk in terms of short-term price fluctuations for HIVE.Check NABL's competition here
TaskUs, Inc. (NASDAQ: TASK)
HIVE vs TASK Comparison September 2026
HIVE Digital Technologies Ltd. (NASDAQ: HIVE) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HIVE stands at 834.6M. In comparison, TASK has a market cap of 728.9M. Regarding current trading prices, HIVE is priced at $3.05 on the NASDAQ, while TASK trades at $8.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HIVE currently has a P/E ratio of -2.50, whereas TASK's P/E ratio is 5.39. In terms of profitability, HIVE's ROE is -0.60%, compared to TASK's ROE of +0.25%. Regarding short-term risk, HIVE is more volatile compared to TASK. This indicates higher risk in terms of short-term price fluctuations for HIVE.Check TASK's competition here
WhiteFiber, Inc. Ordinary Shares (NASDAQ: WYFI)
HIVE vs WYFI Comparison September 2026
HIVE Digital Technologies Ltd. (NASDAQ: HIVE) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HIVE stands at 834.6M. In comparison, WYFI has a market cap of 725.2M. Regarding current trading prices, HIVE is priced at $3.05 on the NASDAQ, while WYFI trades at $18.78.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HIVE currently has a P/E ratio of -2.50, whereas WYFI's P/E ratio is -11.16. In terms of profitability, HIVE's ROE is -0.60%, compared to WYFI's ROE of -0.09%. Regarding short-term risk, HIVE is more volatile compared to WYFI. This indicates higher risk in terms of short-term price fluctuations for HIVE.Check WYFI's competition here
Grid Dynamics Holdings, Inc. (NASDAQ: GDYN)
HIVE vs GDYN Comparison September 2026
HIVE Digital Technologies Ltd. (NASDAQ: HIVE) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HIVE stands at 834.6M. In comparison, GDYN has a market cap of 665.2M. Regarding current trading prices, HIVE is priced at $3.05 on the NASDAQ, while GDYN trades at $8.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HIVE currently has a P/E ratio of -2.50, whereas GDYN's P/E ratio is 21.58. In terms of profitability, HIVE's ROE is -0.60%, compared to GDYN's ROE of +0.01%. Regarding short-term risk, HIVE is more volatile compared to GDYN. This indicates higher risk in terms of short-term price fluctuations for HIVE.Check GDYN's competition here
Verra Mobility Corporation (NASDAQ: VRRM)
HIVE vs VRRM Comparison September 2026
HIVE Digital Technologies Ltd. (NASDAQ: HIVE) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HIVE stands at 834.6M. In comparison, VRRM has a market cap of 638M. Regarding current trading prices, HIVE is priced at $3.05 on the NASDAQ, while VRRM trades at $4.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HIVE currently has a P/E ratio of -2.50, whereas VRRM's P/E ratio is 3.23. In terms of profitability, HIVE's ROE is -0.60%, compared to VRRM's ROE of +0.15%. Regarding short-term risk, HIVE is more volatile compared to VRRM. This indicates higher risk in terms of short-term price fluctuations for HIVE.Check VRRM's competition here
Performant Healthcare, Inc. (NASDAQ: PHLT)
HIVE vs PHLT Comparison September 2026
HIVE Digital Technologies Ltd. (NASDAQ: HIVE) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HIVE stands at 834.6M. In comparison, PHLT has a market cap of 611.6M. Regarding current trading prices, HIVE is priced at $3.05 on the NASDAQ, while PHLT trades at $7.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HIVE currently has a P/E ratio of -2.50, whereas PHLT's P/E ratio is -775.00. In terms of profitability, HIVE's ROE is -0.60%, compared to PHLT's ROE of +0.02%. Regarding short-term risk, HIVE is more volatile compared to PHLT. This indicates higher risk in terms of short-term price fluctuations for HIVE.Check PHLT's competition here
BigBear.ai Holdings, Inc. WT (NYSE: BBAI-WT)
HIVE vs BBAI-WT Comparison September 2026
HIVE Digital Technologies Ltd. (NASDAQ: HIVE) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HIVE stands at 834.6M. In comparison, BBAI-WT has a market cap of 576.6M. Regarding current trading prices, HIVE is priced at $3.05 on the NASDAQ, while BBAI-WT trades at $0.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HIVE currently has a P/E ratio of -2.50, whereas BBAI-WT's P/E ratio is -0.07. In terms of profitability, HIVE's ROE is -0.60%, compared to BBAI-WT's ROE of -0.12%. Regarding short-term risk, HIVE is less volatile compared to BBAI-WT. This indicates lower risk in terms of short-term price fluctuations for HIVE.Check BBAI-WT's competition here
IBEX Limited (NASDAQ: IBEX)
HIVE vs IBEX Comparison September 2026
HIVE Digital Technologies Ltd. (NASDAQ: HIVE) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HIVE stands at 834.6M. In comparison, IBEX has a market cap of 527.7M. Regarding current trading prices, HIVE is priced at $3.05 on the NASDAQ, while IBEX trades at $39.41.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HIVE currently has a P/E ratio of -2.50, whereas IBEX's P/E ratio is 11.10. In terms of profitability, HIVE's ROE is -0.60%, compared to IBEX's ROE of +0.32%. Regarding short-term risk, HIVE is more volatile compared to IBEX. This indicates higher risk in terms of short-term price fluctuations for HIVE.Check IBEX's competition here
Alight, Inc. (NYSE: ALIT)
HIVE vs ALIT Comparison September 2026
HIVE Digital Technologies Ltd. (NASDAQ: HIVE) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HIVE stands at 834.6M. In comparison, ALIT has a market cap of 392M. Regarding current trading prices, HIVE is priced at $3.05 on the NASDAQ, while ALIT trades at $14.89.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HIVE currently has a P/E ratio of -2.50, whereas ALIT's P/E ratio is 6.17. In terms of profitability, HIVE's ROE is -0.60%, compared to ALIT's ROE of -1.59%. Regarding short-term risk, HIVE is more volatile compared to ALIT. This indicates higher risk in terms of short-term price fluctuations for HIVE.Check ALIT's competition here
Telos Corporation (NASDAQ: TLS)
HIVE vs TLS Comparison September 2026
HIVE Digital Technologies Ltd. (NASDAQ: HIVE) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HIVE stands at 834.6M. In comparison, TLS has a market cap of 364.4M. Regarding current trading prices, HIVE is priced at $3.05 on the NASDAQ, while TLS trades at $4.87.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HIVE currently has a P/E ratio of -2.50, whereas TLS's P/E ratio is 27.06. In terms of profitability, HIVE's ROE is -0.60%, compared to TLS's ROE of -0.16%. Regarding short-term risk, HIVE is more volatile compared to TLS. This indicates higher risk in terms of short-term price fluctuations for HIVE.Check TLS's competition here
Conduent Incorporated (NASDAQ: CNDT)
HIVE vs CNDT Comparison September 2026
HIVE Digital Technologies Ltd. (NASDAQ: HIVE) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HIVE stands at 834.6M. In comparison, CNDT has a market cap of 293.1M. Regarding current trading prices, HIVE is priced at $3.05 on the NASDAQ, while CNDT trades at $1.89.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HIVE currently has a P/E ratio of -2.50, whereas CNDT's P/E ratio is -4.97. In terms of profitability, HIVE's ROE is -0.60%, compared to CNDT's ROE of -0.30%. Regarding short-term risk, HIVE is more volatile compared to CNDT. This indicates higher risk in terms of short-term price fluctuations for HIVE.Check CNDT's competition here
The Hackett Group, Inc. (NASDAQ: HCKT)
HIVE vs HCKT Comparison September 2026
HIVE Digital Technologies Ltd. (NASDAQ: HIVE) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HIVE stands at 834.6M. In comparison, HCKT has a market cap of 279.1M. Regarding current trading prices, HIVE is priced at $3.05 on the NASDAQ, while HCKT trades at $11.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HIVE currently has a P/E ratio of -2.50, whereas HCKT's P/E ratio is 7.64. In terms of profitability, HIVE's ROE is -0.60%, compared to HCKT's ROE of +0.22%. Regarding short-term risk, HIVE is more volatile compared to HCKT. This indicates higher risk in terms of short-term price fluctuations for HIVE.Check HCKT's competition here
Webull Corporation Incentive Warrant (NASDAQ: BULLZ)
HIVE vs BULLZ Comparison September 2026
HIVE Digital Technologies Ltd. (NASDAQ: HIVE) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HIVE stands at 834.6M. In comparison, BULLZ has a market cap of 260.4M. Regarding current trading prices, HIVE is priced at $3.05 on the NASDAQ, while BULLZ trades at $1.87.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HIVE currently has a P/E ratio of -2.50, whereas BULLZ's P/E ratio is N/A. In terms of profitability, HIVE's ROE is -0.60%, compared to BULLZ's ROE of +0.04%. Regarding short-term risk, HIVE is less volatile compared to BULLZ. This indicates lower risk in terms of short-term price fluctuations for HIVE.Check BULLZ's competition here
TSS, Inc. (NASDAQ: TSSI)
HIVE vs TSSI Comparison September 2026
HIVE Digital Technologies Ltd. (NASDAQ: HIVE) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HIVE stands at 834.6M. In comparison, TSSI has a market cap of 227.4M. Regarding current trading prices, HIVE is priced at $3.05 on the NASDAQ, while TSSI trades at $8.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HIVE currently has a P/E ratio of -2.50, whereas TSSI's P/E ratio is 16.53. In terms of profitability, HIVE's ROE is -0.60%, compared to TSSI's ROE of +0.19%. Regarding short-term risk, HIVE is more volatile compared to TSSI. This indicates higher risk in terms of short-term price fluctuations for HIVE.Check TSSI's competition here
Unisys Corporation (NYSE: UIS)
HIVE vs UIS Comparison September 2026
HIVE Digital Technologies Ltd. (NASDAQ: HIVE) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HIVE stands at 834.6M. In comparison, UIS has a market cap of 189.2M. Regarding current trading prices, HIVE is priced at $3.05 on the NASDAQ, while UIS trades at $2.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HIVE currently has a P/E ratio of -2.50, whereas UIS's P/E ratio is 3.13. In terms of profitability, HIVE's ROE is -0.60%, compared to UIS's ROE of +1.35%. Regarding short-term risk, HIVE is more volatile compared to UIS. This indicates higher risk in terms of short-term price fluctuations for HIVE.Check UIS's competition here
Startek, Inc. (NYSE: SRT)
HIVE vs SRT Comparison September 2026
HIVE Digital Technologies Ltd. (NASDAQ: HIVE) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HIVE stands at 834.6M. In comparison, SRT has a market cap of 178.3M. Regarding current trading prices, HIVE is priced at $3.05 on the NASDAQ, while SRT trades at $4.42.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HIVE currently has a P/E ratio of -2.50, whereas SRT's P/E ratio is -6.60. In terms of profitability, HIVE's ROE is -0.60%, compared to SRT's ROE of -0.00%. Regarding short-term risk, HIVE is more volatile compared to SRT. This indicates higher risk in terms of short-term price fluctuations for HIVE.Check SRT's competition here
Robot Consulting Co., Ltd. ADS (NASDAQ: LAWR)
HIVE vs LAWR Comparison September 2026
HIVE Digital Technologies Ltd. (NASDAQ: HIVE) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HIVE stands at 834.6M. In comparison, LAWR has a market cap of 172.4M. Regarding current trading prices, HIVE is priced at $3.05 on the NASDAQ, while LAWR trades at $3.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HIVE currently has a P/E ratio of -2.50, whereas LAWR's P/E ratio is -53.57. In terms of profitability, HIVE's ROE is -0.60%, compared to LAWR's ROE of +1.39%. Regarding short-term risk, HIVE is more volatile compared to LAWR. This indicates higher risk in terms of short-term price fluctuations for HIVE.Check LAWR's competition here
Computer Task Group, Incorporated (NASDAQ: CTG)
HIVE vs CTG Comparison September 2026
HIVE Digital Technologies Ltd. (NASDAQ: HIVE) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HIVE stands at 834.6M. In comparison, CTG has a market cap of 169M. Regarding current trading prices, HIVE is priced at $3.05 on the NASDAQ, while CTG trades at $10.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HIVE currently has a P/E ratio of -2.50, whereas CTG's P/E ratio is 350.00. In terms of profitability, HIVE's ROE is -0.60%, compared to CTG's ROE of +0.07%. Regarding short-term risk, HIVE is more volatile compared to CTG. This indicates higher risk in terms of short-term price fluctuations for HIVE.Check CTG's competition here
Endava plc (NYSE: DAVA)
HIVE vs DAVA Comparison September 2026
HIVE Digital Technologies Ltd. (NASDAQ: HIVE) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HIVE stands at 834.6M. In comparison, DAVA has a market cap of 165.8M. Regarding current trading prices, HIVE is priced at $3.05 on the NASDAQ, while DAVA trades at $3.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HIVE currently has a P/E ratio of -2.50, whereas DAVA's P/E ratio is 3.87. In terms of profitability, HIVE's ROE is -0.60%, compared to DAVA's ROE of -0.88%. Regarding short-term risk, HIVE is more volatile compared to DAVA. This indicates higher risk in terms of short-term price fluctuations for HIVE.Check DAVA's competition here
KORE Group Holdings, Inc. (NYSE: KORE)
HIVE vs KORE Comparison September 2026
HIVE Digital Technologies Ltd. (NASDAQ: HIVE) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HIVE stands at 834.6M. In comparison, KORE has a market cap of 163M. Regarding current trading prices, HIVE is priced at $3.05 on the NASDAQ, while KORE trades at $9.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HIVE currently has a P/E ratio of -2.50, whereas KORE's P/E ratio is -4.97. In terms of profitability, HIVE's ROE is -0.60%, compared to KORE's ROE of +0.48%. Regarding short-term risk, HIVE is more volatile compared to KORE. This indicates higher risk in terms of short-term price fluctuations for HIVE.Check KORE's competition here
Alithya Group Inc. (NASDAQ: ALYA)
HIVE vs ALYA Comparison September 2026
HIVE Digital Technologies Ltd. (NASDAQ: HIVE) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HIVE stands at 834.6M. In comparison, ALYA has a market cap of 110.3M. Regarding current trading prices, HIVE is priced at $3.05 on the NASDAQ, while ALYA trades at $1.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HIVE currently has a P/E ratio of -2.50, whereas ALYA's P/E ratio is -3.42. In terms of profitability, HIVE's ROE is -0.60%, compared to ALYA's ROE of -0.09%. Regarding short-term risk, HIVE is more volatile compared to ALYA. This indicates higher risk in terms of short-term price fluctuations for HIVE.Check ALYA's competition here
WidePoint Corporation (AMEX: WYY)
HIVE vs WYY Comparison September 2026
HIVE Digital Technologies Ltd. (NASDAQ: HIVE) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HIVE stands at 834.6M. In comparison, WYY has a market cap of 109.5M. Regarding current trading prices, HIVE is priced at $3.05 on the NASDAQ, while WYY trades at $11.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HIVE currently has a P/E ratio of -2.50, whereas WYY's P/E ratio is -85.15. In terms of profitability, HIVE's ROE is -0.60%, compared to WYY's ROE of -0.11%. Regarding short-term risk, HIVE is more volatile compared to WYY. This indicates higher risk in terms of short-term price fluctuations for HIVE.Check WYY's competition here
ZenaTech, Inc. (NASDAQ: ZENA)
HIVE vs ZENA Comparison September 2026
HIVE Digital Technologies Ltd. (NASDAQ: HIVE) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HIVE stands at 834.6M. In comparison, ZENA has a market cap of 105.1M. Regarding current trading prices, HIVE is priced at $3.05 on the NASDAQ, while ZENA trades at $1.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HIVE currently has a P/E ratio of -2.50, whereas ZENA's P/E ratio is -1.05. In terms of profitability, HIVE's ROE is -0.60%, compared to ZENA's ROE of -1.21%. Regarding short-term risk, HIVE is more volatile compared to ZENA. This indicates higher risk in terms of short-term price fluctuations for HIVE.Check ZENA's competition here
Yuanbao Inc. American Depositary Shares (NASDAQ: YB)
HIVE vs YB Comparison September 2026
HIVE Digital Technologies Ltd. (NASDAQ: HIVE) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HIVE stands at 834.6M. In comparison, YB has a market cap of 103.8M. Regarding current trading prices, HIVE is priced at $3.05 on the NASDAQ, while YB trades at $13.62.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HIVE currently has a P/E ratio of -2.50, whereas YB's P/E ratio is 3.12. In terms of profitability, HIVE's ROE is -0.60%, compared to YB's ROE of +0.44%. Regarding short-term risk, HIVE is more volatile compared to YB. This indicates higher risk in terms of short-term price fluctuations for HIVE.Check YB's competition here
Exascale Labs Holdings Inc. (NASDAQ: XLAB)
HIVE vs XLAB Comparison September 2026
HIVE Digital Technologies Ltd. (NASDAQ: HIVE) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HIVE stands at 834.6M. In comparison, XLAB has a market cap of 100.6M. Regarding current trading prices, HIVE is priced at $3.05 on the NASDAQ, while XLAB trades at $4.72.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HIVE currently has a P/E ratio of -2.50, whereas XLAB's P/E ratio is 23.15. In terms of profitability, HIVE's ROE is -0.60%, compared to XLAB's ROE of N/A. Regarding short-term risk, HIVE is less volatile compared to XLAB. This indicates lower risk in terms of short-term price fluctuations for HIVE.Check XLAB's competition here
CSP Inc. (NASDAQ: CSPI)
HIVE vs CSPI Comparison September 2026
HIVE Digital Technologies Ltd. (NASDAQ: HIVE) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HIVE stands at 834.6M. In comparison, CSPI has a market cap of 81.4M. Regarding current trading prices, HIVE is priced at $3.05 on the NASDAQ, while CSPI trades at $8.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HIVE currently has a P/E ratio of -2.50, whereas CSPI's P/E ratio is -115.43. In terms of profitability, HIVE's ROE is -0.60%, compared to CSPI's ROE of -0.02%. Regarding short-term risk, HIVE is more volatile compared to CSPI. This indicates higher risk in terms of short-term price fluctuations for HIVE.Check CSPI's competition here
ChronoScale Corporation (NASDAQ: CHRN)
HIVE vs CHRN Comparison September 2026
HIVE Digital Technologies Ltd. (NASDAQ: HIVE) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HIVE stands at 834.6M. In comparison, CHRN has a market cap of 71.6M. Regarding current trading prices, HIVE is priced at $3.05 on the NASDAQ, while CHRN trades at $20.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HIVE currently has a P/E ratio of -2.50, whereas CHRN's P/E ratio is -3.54. In terms of profitability, HIVE's ROE is -0.60%, compared to CHRN's ROE of N/A. Regarding short-term risk, HIVE is more volatile compared to CHRN. This indicates higher risk in terms of short-term price fluctuations for HIVE.Check CHRN's competition here
TTEC Holdings, Inc. (NASDAQ: TTEC)
HIVE vs TTEC Comparison September 2026
HIVE Digital Technologies Ltd. (NASDAQ: HIVE) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HIVE stands at 834.6M. In comparison, TTEC has a market cap of 67.1M. Regarding current trading prices, HIVE is priced at $3.05 on the NASDAQ, while TTEC trades at $1.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HIVE currently has a P/E ratio of -2.50, whereas TTEC's P/E ratio is 1.44. In terms of profitability, HIVE's ROE is -0.60%, compared to TTEC's ROE of -1.62%. Regarding short-term risk, HIVE is more volatile compared to TTEC. This indicates higher risk in terms of short-term price fluctuations for HIVE.Check TTEC's competition here
Quantum X Labs Inc. (NASDAQ: QXL)
HIVE vs QXL Comparison September 2026
HIVE Digital Technologies Ltd. (NASDAQ: HIVE) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HIVE stands at 834.6M. In comparison, QXL has a market cap of 61.3M. Regarding current trading prices, HIVE is priced at $3.05 on the NASDAQ, while QXL trades at $4.62.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HIVE currently has a P/E ratio of -2.50, whereas QXL's P/E ratio is -92.00. In terms of profitability, HIVE's ROE is -0.60%, compared to QXL's ROE of -0.14%. Regarding short-term risk, HIVE is more volatile compared to QXL. This indicates higher risk in terms of short-term price fluctuations for HIVE.Check QXL's competition here
Castellum, Inc. (AMEX: CTM)
HIVE vs CTM Comparison September 2026
HIVE Digital Technologies Ltd. (NASDAQ: HIVE) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HIVE stands at 834.6M. In comparison, CTM has a market cap of 57.1M. Regarding current trading prices, HIVE is priced at $3.05 on the NASDAQ, while CTM trades at $0.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HIVE currently has a P/E ratio of -2.50, whereas CTM's P/E ratio is -46.10. In terms of profitability, HIVE's ROE is -0.60%, compared to CTM's ROE of -0.06%. Regarding short-term risk, HIVE is more volatile compared to CTM. This indicates higher risk in terms of short-term price fluctuations for HIVE.Check CTM's competition here
SAIHEAT Limited (NASDAQ: SAIH)
HIVE vs SAIH Comparison September 2026
HIVE Digital Technologies Ltd. (NASDAQ: HIVE) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HIVE stands at 834.6M. In comparison, SAIH has a market cap of 45.9M. Regarding current trading prices, HIVE is priced at $3.05 on the NASDAQ, while SAIH trades at $25.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HIVE currently has a P/E ratio of -2.50, whereas SAIH's P/E ratio is -4.56. In terms of profitability, HIVE's ROE is -0.60%, compared to SAIH's ROE of -0.68%. Regarding short-term risk, HIVE is more volatile compared to SAIH. This indicates higher risk in terms of short-term price fluctuations for HIVE.Check SAIH's competition here
Sify Technologies Limited Rights expiring 6/21/2024 (NASDAQ: SIFYR)
HIVE vs SIFYR Comparison September 2026
HIVE Digital Technologies Ltd. (NASDAQ: HIVE) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HIVE stands at 834.6M. In comparison, SIFYR has a market cap of 44.3M. Regarding current trading prices, HIVE is priced at $3.05 on the NASDAQ, while SIFYR trades at $0.18.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HIVE currently has a P/E ratio of -2.50, whereas SIFYR's P/E ratio is N/A. In terms of profitability, HIVE's ROE is -0.60%, compared to SIFYR's ROE of N/A. Regarding short-term risk, HIVE is less volatile compared to SIFYR. This indicates lower risk in terms of short-term price fluctuations for HIVE.Check SIFYR's competition here
Ekso Bionics Holdings, Inc. (NASDAQ: EKSO)
HIVE vs EKSO Comparison September 2026
HIVE Digital Technologies Ltd. (NASDAQ: HIVE) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HIVE stands at 834.6M. In comparison, EKSO has a market cap of 38.6M. Regarding current trading prices, HIVE is priced at $3.05 on the NASDAQ, while EKSO trades at $15.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HIVE currently has a P/E ratio of -2.50, whereas EKSO's P/E ratio is -3.11. In terms of profitability, HIVE's ROE is -0.60%, compared to EKSO's ROE of -1.77%. Regarding short-term risk, HIVE is less volatile compared to EKSO. This indicates lower risk in terms of short-term price fluctuations for HIVE.Check EKSO's competition here
CLPS Incorporation (NASDAQ: CLPS)
HIVE vs CLPS Comparison September 2026
HIVE Digital Technologies Ltd. (NASDAQ: HIVE) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HIVE stands at 834.6M. In comparison, CLPS has a market cap of 31.6M. Regarding current trading prices, HIVE is priced at $3.05 on the NASDAQ, while CLPS trades at $1.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HIVE currently has a P/E ratio of -2.50, whereas CLPS's P/E ratio is -4.47. In terms of profitability, HIVE's ROE is -0.60%, compared to CLPS's ROE of -0.12%. Regarding short-term risk, HIVE is more volatile compared to CLPS. This indicates higher risk in terms of short-term price fluctuations for HIVE.Check CLPS's competition here
9F Inc. (NASDAQ: JFU)
HIVE vs JFU Comparison September 2026
HIVE Digital Technologies Ltd. (NASDAQ: HIVE) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HIVE stands at 834.6M. In comparison, JFU has a market cap of 29.7M. Regarding current trading prices, HIVE is priced at $3.05 on the NASDAQ, while JFU trades at $2.52.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HIVE currently has a P/E ratio of -2.50, whereas JFU's P/E ratio is 540.77. In terms of profitability, HIVE's ROE is -0.60%, compared to JFU's ROE of +0.04%. Regarding short-term risk, HIVE is more volatile compared to JFU. This indicates higher risk in terms of short-term price fluctuations for HIVE.Check JFU's competition here
ChowChow Cloud International Holdings Ltd. (AMEX: CHOW)
HIVE vs CHOW Comparison September 2026
HIVE Digital Technologies Ltd. (NASDAQ: HIVE) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HIVE stands at 834.6M. In comparison, CHOW has a market cap of 16.8M. Regarding current trading prices, HIVE is priced at $3.05 on the NASDAQ, while CHOW trades at $0.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HIVE currently has a P/E ratio of -2.50, whereas CHOW's P/E ratio is -5.25. In terms of profitability, HIVE's ROE is -0.60%, compared to CHOW's ROE of -0.58%. Regarding short-term risk, HIVE is less volatile compared to CHOW. This indicates lower risk in terms of short-term price fluctuations for HIVE.Check CHOW's competition here
Global Engine Group Holding Limited Ordinary Shares (NASDAQ: GLE)
HIVE vs GLE Comparison September 2026
HIVE Digital Technologies Ltd. (NASDAQ: HIVE) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HIVE stands at 834.6M. In comparison, GLE has a market cap of 11.7M. Regarding current trading prices, HIVE is priced at $3.05 on the NASDAQ, while GLE trades at $0.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HIVE currently has a P/E ratio of -2.50, whereas GLE's P/E ratio is -7.29. In terms of profitability, HIVE's ROE is -0.60%, compared to GLE's ROE of +0.20%. Regarding short-term risk, HIVE is more volatile compared to GLE. This indicates higher risk in terms of short-term price fluctuations for HIVE.Check GLE's competition here
Sigma Labs, Inc. (NASDAQ: SGLB)
HIVE vs SGLB Comparison September 2026
HIVE Digital Technologies Ltd. (NASDAQ: HIVE) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HIVE stands at 834.6M. In comparison, SGLB has a market cap of 11.3M. Regarding current trading prices, HIVE is priced at $3.05 on the NASDAQ, while SGLB trades at $1.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HIVE currently has a P/E ratio of -2.50, whereas SGLB's P/E ratio is -1.37. In terms of profitability, HIVE's ROE is -0.60%, compared to SGLB's ROE of -2.65%. Regarding short-term risk, HIVE is more volatile compared to SGLB. This indicates higher risk in terms of short-term price fluctuations for HIVE.Check SGLB's competition here
Alarum Technologies Ltd. (NASDAQ: ALAR)
HIVE vs ALAR Comparison September 2026
HIVE Digital Technologies Ltd. (NASDAQ: HIVE) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HIVE stands at 834.6M. In comparison, ALAR has a market cap of 9.7M. Regarding current trading prices, HIVE is priced at $3.05 on the NASDAQ, while ALAR trades at $1.32.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HIVE currently has a P/E ratio of -2.50, whereas ALAR's P/E ratio is 2.16. In terms of profitability, HIVE's ROE is -0.60%, compared to ALAR's ROE of +0.04%. Regarding short-term risk, HIVE is more volatile compared to ALAR. This indicates higher risk in terms of short-term price fluctuations for HIVE.Check ALAR's competition here
LZ Technology Holdings Limited Class B Ordinary Shares (NASDAQ: LZMH)
HIVE vs LZMH Comparison September 2026
HIVE Digital Technologies Ltd. (NASDAQ: HIVE) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HIVE stands at 834.6M. In comparison, LZMH has a market cap of 9.7M. Regarding current trading prices, HIVE is priced at $3.05 on the NASDAQ, while LZMH trades at $1.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HIVE currently has a P/E ratio of -2.50, whereas LZMH's P/E ratio is -0.37. In terms of profitability, HIVE's ROE is -0.60%, compared to LZMH's ROE of -3.05%. Regarding short-term risk, HIVE is more volatile compared to LZMH. This indicates higher risk in terms of short-term price fluctuations for HIVE.Check LZMH's competition here
ARB IOT Group Limited (NASDAQ: ARBB)
HIVE vs ARBB Comparison September 2026
HIVE Digital Technologies Ltd. (NASDAQ: HIVE) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HIVE stands at 834.6M. In comparison, ARBB has a market cap of 7.5M. Regarding current trading prices, HIVE is priced at $3.05 on the NASDAQ, while ARBB trades at $4.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HIVE currently has a P/E ratio of -2.50, whereas ARBB's P/E ratio is -0.56. In terms of profitability, HIVE's ROE is -0.60%, compared to ARBB's ROE of -0.07%. Regarding short-term risk, HIVE is more volatile compared to ARBB. This indicates higher risk in terms of short-term price fluctuations for HIVE.Check ARBB's competition here
Trident Digital Tech Holdings Ltd (NASDAQ: TDTH)
HIVE vs TDTH Comparison September 2026
HIVE Digital Technologies Ltd. (NASDAQ: HIVE) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HIVE stands at 834.6M. In comparison, TDTH has a market cap of 7.1M. Regarding current trading prices, HIVE is priced at $3.05 on the NASDAQ, while TDTH trades at $1.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HIVE currently has a P/E ratio of -2.50, whereas TDTH's P/E ratio is -0.26. In terms of profitability, HIVE's ROE is -0.60%, compared to TDTH's ROE of +3.18%. Regarding short-term risk, HIVE is more volatile compared to TDTH. This indicates higher risk in terms of short-term price fluctuations for HIVE.Check TDTH's competition here
Data Storage Corporation (NASDAQ: DTST)
HIVE vs DTST Comparison September 2026
HIVE Digital Technologies Ltd. (NASDAQ: HIVE) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HIVE stands at 834.6M. In comparison, DTST has a market cap of 6.5M. Regarding current trading prices, HIVE is priced at $3.05 on the NASDAQ, while DTST trades at $2.97.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HIVE currently has a P/E ratio of -2.50, whereas DTST's P/E ratio is 43.00. In terms of profitability, HIVE's ROE is -0.60%, compared to DTST's ROE of +0.71%. Regarding short-term risk, HIVE is more volatile compared to DTST. This indicates higher risk in terms of short-term price fluctuations for HIVE.Check DTST's competition here
Cycurion, Inc. Common Stock (NASDAQ: CYCU)
HIVE vs CYCU Comparison September 2026
HIVE Digital Technologies Ltd. (NASDAQ: HIVE) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HIVE stands at 834.6M. In comparison, CYCU has a market cap of 4.8M. Regarding current trading prices, HIVE is priced at $3.05 on the NASDAQ, while CYCU trades at $3.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HIVE currently has a P/E ratio of -2.50, whereas CYCU's P/E ratio is -0.41. In terms of profitability, HIVE's ROE is -0.60%, compared to CYCU's ROE of -0.71%. Regarding short-term risk, HIVE is less volatile compared to CYCU. This indicates lower risk in terms of short-term price fluctuations for HIVE.Check CYCU's competition here
Veea Inc. (NASDAQ: VEEA)
HIVE vs VEEA Comparison September 2026
HIVE Digital Technologies Ltd. (NASDAQ: HIVE) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HIVE stands at 834.6M. In comparison, VEEA has a market cap of 4.7M. Regarding current trading prices, HIVE is priced at $3.05 on the NASDAQ, while VEEA trades at $1.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HIVE currently has a P/E ratio of -2.50, whereas VEEA's P/E ratio is -21.50. In terms of profitability, HIVE's ROE is -0.60%, compared to VEEA's ROE of +51.66%. Regarding short-term risk, HIVE is more volatile compared to VEEA. This indicates higher risk in terms of short-term price fluctuations for HIVE.Check VEEA's competition here
CID HoldCo, Inc. (NASDAQ: DAIC)
HIVE vs DAIC Comparison September 2026
HIVE Digital Technologies Ltd. (NASDAQ: HIVE) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HIVE stands at 834.6M. In comparison, DAIC has a market cap of 4M. Regarding current trading prices, HIVE is priced at $3.05 on the NASDAQ, while DAIC trades at $3.34.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HIVE currently has a P/E ratio of -2.50, whereas DAIC's P/E ratio is -0.07. In terms of profitability, HIVE's ROE is -0.60%, compared to DAIC's ROE of +37.71%. Regarding short-term risk, HIVE is more volatile compared to DAIC. This indicates higher risk in terms of short-term price fluctuations for HIVE.Check DAIC's competition here